Commodore Capital L.P., 10% Owner at Vistagen Therapeutics, Inc. (VTGN), bought 775,756 shares at $23.15 ($18.0M) on 2023-08-07, disclosed to the SEC on 2023-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |
| STSA | SELL | 2022-11-16 | $2.3M | — | Filing → |